Trials / Unknown
UnknownNCT04878276
Comparative Head Lice Therapy With Dimet 5® vs. Hedrin® Once
Randomised, Investigator-blinded, Controlled, Multicentre Comparative Study on the Treatment of Head Lice Infestation With 2 Dimeticone Preparations With Different Application Times and Compositions: Dimet 5® (100% Dimeticon) Versus Hedrin® Once Liquid Gel (4% Dimeticon + Nerolidol)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Infectopharm Arzneimittel GmbH · Industry
- Sex
- All
- Age
- 6 Months – 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, investigator-blinded, controlled, multicenter comparative study on the treatment of acute head lice infestation in children with 2 dimeticone preparations with different application times and compositions: Dimet 5® (100% dimeticone) versus Hedrin® Once Liquid Gel (4% dimeticone + nerolidol) with treatment success assessment via freedom from infestation of live head lice at final examination at V2, i.e. day 19 after first treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dimet 5 | The application is carried out according to the enclosed instructions for use. |
Timeline
- Start date
- 2021-05-17
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2021-05-07
- Last updated
- 2024-03-06
Locations
26 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04878276. Inclusion in this directory is not an endorsement.